Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"X-ray beam" does not refer to a molecule, receptor, or biological therapeutic target. Instead, it describes a stream of X-ray photons—a form of high-energy electromagnetic radiation—produced typically in an X-ray tube when high-energy electrons strike a metal target. X-rays have wavelengths shorter than ultraviolet rays and longer than gamma rays, corresponding to photon energies generally in the range of 100 eV to 100 keV[2][3][4]. X-ray beams are polyenergetic (containing a range of photon energies), and their properties (energy, intensity, direction) can be tailored for medical imaging, material analysis, and therapeutic purposes[1][5][7]. The X-ray beam itself is not a biological or protein-based structure, so it does not have drug interactions, molecular classification, or traditional disease roles as would be the case for a biological therapeutic target. In summary, "X-ray beam" is not a canonical molecular or receptor target, but rather a form of physical energy used diagnostically and therapeutically, with known safety risks primarily due to its ionizing radiation[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray beam.